<--- Back to Details
First PageDocument Content
Food and Drug Administration / Pharmaceuticals policy / Healthcare quality / Prescription Drug User Fee Act / Federal Food /  Drug /  and Cosmetic Act / Abbreviated New Drug Application / Compounding / United States Code / Controlled Substances Penalties Amendments Act / Industrial Hemp Farming Act
Date: 2012-03-21 10:56:20
Food and Drug Administration
Pharmaceuticals policy
Healthcare quality
Prescription Drug User Fee Act
Federal Food
Drug
and Cosmetic Act
Abbreviated New Drug Application
Compounding
United States Code
Controlled Substances Penalties Amendments Act
Industrial Hemp Farming Act

PUBLIC LAW 105–115—NOV. 21, 1997 FOOD AND DRUG ADMINISTRATION MODERIZATION ACT OF 1997 111 STAT. 2296

Add to Reading List

Source URL: www.gpo.gov

Download Document from Source Website

File Size: 451,12 KB

Share Document on Facebook

Similar Documents

NEWS  The Cosmetics Industry OVERVIEW In the United States cosmetics are officially regulated by the Food & Drug Administration as a result of the Food, Drug and Cosmetic Act passed inThere is also a self-regulato

NEWS The Cosmetics Industry OVERVIEW In the United States cosmetics are officially regulated by the Food & Drug Administration as a result of the Food, Drug and Cosmetic Act passed inThere is also a self-regulato

DocID: 1uASt - View Document

Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry

Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry

DocID: 1tBOU - View Document

RETAIL COMPLIANCE CHECK INSPECTIONS AND FDA ACTIONS: AN OVERVIEW FOR TOBACCO RETAILERS Presented by Michelle Jackson

RETAIL COMPLIANCE CHECK INSPECTIONS AND FDA ACTIONS: AN OVERVIEW FOR TOBACCO RETAILERS Presented by Michelle Jackson

DocID: 1roDS - View Document

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

DocID: 1rmMY - View Document

Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices - Draft Guidance for Industry and Food and Drug Administration Staff

Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices - Draft Guidance for Industry and Food and Drug Administration Staff

DocID: 1r7Xt - View Document